HomeComparePNNT vs CAH

PNNT vs CAH: Dividend Comparison 2026

PNNT yields 21.82% · CAH yields 0.99%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PNNT wins by $2487.10M in total portfolio value
10 years
PNNT
PNNT
● Live price
21.82%
Share price
$4.40
Annual div
$0.96
5Y div CAGR
57.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2487.12M
Annual income
$2,270,557,040.91
Full PNNT calculator →
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →

Portfolio growth — PNNT vs CAH

📍 PNNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPNNTCAH
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PNNT + CAH cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PNNT pays
CAH pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PNNT
Annual income on $10K today (after 15% tax)
$1,854.55/yr
After 10yr DRIP, annual income (after tax)
$1,929,973,484.77/yr
CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
At 15% tax rate, PNNT beats the other by $1,929,973,327.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PNNT + CAH for your $10,000?

PNNT: 50%CAH: 50%
100% CAH50/50100% PNNT
Portfolio after 10yr
$1243.57M
Annual income
$1,135,278,612.97/yr
Blended yield
91.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CAH right now

PNNT
Analyst Ratings
3
Buy
11
Hold
1
Sell
Consensus: Hold
Price Target
$6.17
+40.2% upside vs current
Range: $5.50 — $7.00
Altman Z
-0.1
Piotroski
6/9
CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PNNT buys
0
CAH buys
0
No recent congressional trades found for PNNT or CAH in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPNNTCAH
Forward yield21.82%0.99%
Annual dividend / share$0.96$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.6%5.6%
Portfolio after 10y$2487.12M$21.6K
Annual income after 10y$2,270,557,040.91$185.04
Total dividends collected$2470.97M$1.4K
Payment frequencyquarterlyquarterly
SectorBDCHealthcare
Analyst consensusHoldBuy
Analyst price target$6.17$252.33

Year-by-year: PNNT vs CAH ($10,000, DRIP)

YearPNNT PortfolioPNNT Income/yrCAH PortfolioCAH Income/yrGap
1← crossover$14,139$3,438.55$10,804$104.30+$3.3KPNNT
2$22,289$7,160.64$11,672$111.21+$10.6KPNNT
3$40,476$16,626.77$12,607$118.57+$27.9KPNNT
4$87,781$44,472.18$13,616$126.40+$74.2KPNNT
5$235,984$142,058.38$14,704$134.73+$221.3KPNNT
6$815,001$562,497.15$15,877$143.59+$799.1KPNNT
7$3,733,376$2,861,325.49$17,142$153.02+$3.72MPNNT
8$23,300,323$19,305,611.09$18,504$163.04+$23.28MPNNT
9$202,397,772$177,466,426.06$19,973$173.70+$202.38MPNNT
10$2,487,122,657$2,270,557,040.91$21,557$185.04+$2487.10MPNNT

PNNT vs CAH: Complete Analysis 2026

PNNTBDC

PennantPark Investment Corporation, a business development company is a private equity fund specializes in direct and mezzanine investments in middle market companies. It invests in the form of mezzanine debt, senior secured loans, and equity investments. The fund typically invests in buildings and real estate, hotels, gaming and leisure, technology, telecommunications, transportation, information technology services, electronics, healthcare & pharmaceuticals, education and childcare, financial services, printing and publishing, consumer products, business services, energy & Related Services and utilities, distribution, oil and gas, media, environmental services, aerospace and defense, building materials, capital equipment, chemicals, plastics, & rubber, food & beverage, wholesale, manufacturing and basic industries and retail. It invests in equity securities and debt transactions through preferred stock, common stock, warrants, options, senior secured debt, subordinated debt, subordinated loans, first lien debt, mezzanine loans, and distressed debt securities and private equity co-investments. It seeks to invest in companies based in the United States. The fund seeks to invest between $10 million and $100 million cross the capital structure (senior secured loans, subordinated debt, and other investments) in its portfolio companies with EBITDA between $10 to $50 million. Its mezzanine loans, senior secured loans, and other investments in its portfolio companies are between $15 million and $50 million. The fund may also make non-control equity and debt investments.

Full PNNT Calculator →

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →
📬

Get this PNNT vs CAH comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PNNT vs SCHDPNNT vs JEPIPNNT vs OPNNT vs KOPNNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.